彩虹集團(003023.SZ):2022年度新產品銷售收入佔比逐步提升,新的功能性產品收入貢獻佔大類產品10%左右
格隆匯5月15日丨彩虹集團(003023.SZ)於2023年5月12日召開業績説明會時表示,公司一貫重視技術開發和產品創新,2022年內推出石墨烯、抗菌消臭除蟎、水電分離等各型電熱毯,智能發熱圍巾和背心、電蚊拍等產品面世銷售,持續研發改進天然植物精油系列,圍繞母嬰防護、健康智能、天然環保產品發力創新。新產品銷售收入佔比逐步提升,新的功能性產品收入貢獻佔大類產品10%左右。2023年度公司將加大技術研發投入開發和創新產品,完善既有產品線,增加產品功能賣點,重點關注PTC、NTC等核心技術,強化開發過程管理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.